Performance Evaluation of Elecsys Analysis System for Anti-Cyclic Citrullinated Peptide Detection in Comparison with Commercially Available Elisa Assays in Rheumatoid Arthritis Diagnosis

Bei Cai,Lanlan Wang,Jin Liu,Weihua Feng
DOI: https://doi.org/10.1016/j.clinbiochem.2011.05.021
IF: 3.625
2011-01-01
Clinical Biochemistry
Abstract:Objectives: To evaluate performance consistency of electrochemical luminescence with ELISA for anti-cyclic citrullinated peptide (CCP) antibodies detection and define their diagnostic efficacy on rheumatoid arthritis (RA).Design and methods: Serum anti-CCP antibodies of 144 subjects (93 RA, 17 non-RA autoimmune diseases,11 involution diseases and 23 healthy volunteers) were simultaneously determined by Elecsys assay, Immunoscan CCPlus (R) Euro-diagnostica ELISA kit and Euroimmun anti-CCP ELISA kit.Results: The consistent rate and Kappa coefficients among three assays were all more than 0.97. AUCs of ROC for anti-CCP antibodies detection by Elecsys, Euro-diagnostica ELISA and Euroimmun ELISA assays were respectively 0.790, 0.773 and 0.794 (all P values = 0.000), and under the optimal cutoff values their diagnostic accurate rates for RA diagnosis were 78.47%, 77.08% and 76.39% respectively.Conclusions: The diagnostic performance of Elecsys assay for anti-CCP antibodies detection was satisfactory and comparable to that of classical ELISA assay. Under the same specificity Elecsys assay has a slightly but not significantly higher diagnostic accuracy and sensitivity than ELISA assay. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?